April 27, 2024

ICL invests in breakthrough sustainable protein ingredients startup

Arkeon companies partnering to develop CO2 – derived protein ingredients for food applications, using Arkeon’s carbon conversion process

ICL (NYSE: ICL) (TASE: ICL), a leading global specialty
minerals company, today announced its AgriFood innovation and investment platform, ICL
Planet Startup Hub, has invested €2.75 million in Arkeon, GmbH. The investment will support
Arkeon’s innovative and sustainable one-step fermentation bioprocess, which creates
completely customizable protein ingredients by capturing the greenhouse gas carbon dioxide
(CO 2 ) and converting it into the 20 proteinogenic amino acids necessary for human nutrition.
The resulting alternative proteins are carbon negative and clean-label functional ingredients.
Arkeon’s patented process pioneered the harnessing of carbon dioxide to make protein –
through the use of archaea, a highly resilient single-celled microorganism – without genetic
engineering. Archaea, part of the microbiota of all organisms, naturally feeds on CO 2 and
transforms these environmental emissions into nutritious protein – meaning the process is not
just sustainable, it is also regenerative.
“I dedicated much of the past decade to exploring new and sustainable biotechnological
methods of alternative protein production,” said Gregor Tegl, PhD, co-founder and CEO of
Arkeon. “Our team has harnessed proficiencies in microbiology and gas fermentation to create
an entirely new regenerative food-production system. ICL’s support and partnership will be
instrumental in helping us scale our archaea-derived protein production capabilities.”
“Arkeon has achieved a major breakthrough, by finding a way to nourish people and revitalize
our ecosystems at the same time,” said Hadar Sutovsky, vice president of External Innovation at
ICL, and general manager of ICL Planet. “Arkeon’s dedication to developing a renewable and
easy to use protein is completely in-line with our organization’s commitment to creating
impactful solutions for humanity’s sustainability challenges in the global food markets.”
“Although a young company, Arkeon brings to the table innovative and sustainable technology
for use in creating the next generation of alternative protein products. They also fully align with
ICL Food Specialties growth strategy of pursuing new frontiers in unique and functional
alternative proteins,” added Rado Sporka, vice president of the Food Specialties Commercial
Business for ICL. “As an established corporation, we are able to offer our advanced
infrastructure, extensive experience and accrued insights, plus market and regulatory related
support. We look forward to working with this promising start-up to unlock a whole new food
category based on Arkeon’s unique protein discovery, which is not dependent on land and
requires minimal use of water, providing it with a limited ecological footprint.”
ICL is leading the current SAFE investment round, which totals more than €4 million and
includes other investors, as well. As the newest portfolio member of ICL’s Planet Startup Hub,
Arkeon will have full access to the ICL Food Specialties state-of-the-art R&D labs and

production facilities. Arkeon marks ICL’s third investment over the past 12 months, via its
Planet Startup Hub, which the company launched in 2021. The accelerator was established to
nurture and advance both early stage and pilot-ready innovative companies operating within the
FoodTech and AgriTech domains.

ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced its AgriFood innovation and investment platform, ICL Planet Startup Hub, has invested €2.75 million in Arkeon, GmbH. The investment will support Arkeon’s innovative and sustainable one-step fermentation bioprocess, which creates completely customizable protein ingredients by capturing the greenhouse gas carbon dioxide
(CO2 ) and converting it into the 20 proteinogenic amino acids necessary for human nutrition.
The resulting alternative proteins are carbon negative and clean-label functional ingredients.
Arkeon’s patented process pioneered the harnessing of carbon dioxide to make protein –
through the use of archaea, a highly resilient single-celled microorganism – without genetic
engineering. Archaea, part of the microbiota of all organisms, naturally feeds on CO2 and
transforms these environmental emissions into nutritious protein – meaning the process is not
just sustainable, it is also regenerative.


“I dedicated much of the past decade to exploring new and sustainable biotechnological
methods of alternative protein production,” said Gregor Tegl, PhD, co-founder and CEO of
Arkeon. “Our team has harnessed proficiencies in microbiology and gas fermentation to create
an entirely new regenerative food-production system. ICL’s support and partnership will be
instrumental in helping us scale our archaea-derived protein production capabilities.”
“Arkeon has achieved a major breakthrough, by finding a way to nourish people and revitalize
our ecosystems at the same time,” said Hadar Sutovsky, vice president of External Innovation at
ICL, and general manager of ICL Planet. “Arkeon’s dedication to developing a renewable and
easy to use protein is completely in-line with our organization’s commitment to creating
impactful solutions for humanity’s sustainability challenges in the global food markets.”

The Arkeon team (Photo credit: Christoph Öhlknecht)


“Although a young company, Arkeon brings to the table innovative and sustainable technology
for use in creating the next generation of alternative protein products. They also fully align with
ICL Food Specialties growth strategy of pursuing new frontiers in unique and functional
alternative proteins,” added Rado Sporka, vice president of the Food Specialties Commercial
Business for ICL. “As an established corporation, we are able to offer our advanced
infrastructure, extensive experience and accrued insights, plus market and regulatory related
support. We look forward to working with this promising start-up to unlock a whole new food
category based on Arkeon’s unique protein discovery, which is not dependent on land and
requires minimal use of water, providing it with a limited ecological footprint.”


ICL is leading the current SAFE investment round, which totals more than €4 million and
includes other investors, as well. As the newest portfolio member of ICL’s Planet Startup Hub,
Arkeon will have full access to the ICL Food Specialties state-of-the-art R&D labs and production facilities. Arkeon marks ICL’s third investment over the past 12 months, via its Planet Startup Hub, which the company launched in 2021. The accelerator was established to nurture and advance both early stage and pilot-ready innovative companies operating within the FoodTech and AgriTech domains.

Related articles

Microalgae to be developed for nutraceutical applications

Yemoja joins MIGAL Institute to pioneer major study of microalgae for Inflammatory Bowel Disease Microalgae cultivation start-up Yemoja, Ltd. is joining the MIGAL Galilee Research institute to spearhead an extensive, four-year research initiative to identify algae-sourced compounds with the potential to help manage inflammation andInflammatory Bowel Disease (IBD). Select beneficial algae will be developed into

Brazil-Arab countries to boost bilateral trade

The Arab Brazilian Chamber of Commerce (ABCC) joined a delegation from the Brazilian Ministry of Agriculture, Livestock, and Food Supply (MAPA) as they travelled to Jordan, Egypt, and Morocco with the aim of strengthening bilateral ties. Led by Minister Marcos Montes, the group met with representatives from private companies and government authorities to discuss the